| Study to Evaluate the Effect of Aficamten Administration on QT/QTc Interval (NCT05924815) | Cytokinetics | 2023-05-15 |
| A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma (NCT05765812) | Debiopharm International SA | 2023-05-15 |
| Using Thermography to Assess the Affects of Sildenafil Cream, 3.6% (NCT05765487) | Daré Bioscience, Inc. | 2023-05-13 |
| A Study to Assess NEU-411 in Healthy Participants (NCT05755191) | Neuron23 Inc. | 2023-05-13 |
| A Clinical Trial Study to Evaluate the Pharmacokinetic Interaction and Safety Between BR1019-1 and BR1019-2 in Healthy Adult Subjects (NCT05875259) | Boryung Pharmaceutical Co., Ltd | 2023-05-13 |
| Drug-Drug Interaction Study of Itraconazole With GST-HG171/Ritonavir in Healthy Participants (NCT06087055) | Fujian Akeylink Biotechnology Co., Ltd. | 2023-05-12 |
| Reduced-dose Botox for Urgency Incontinence Among Elder Females (NCT05512039) | Dartmouth-Hitchcock Medical Center | 2023-05-12 |
| Rivastigmine Transdermal Patches Bioequivalence and Adhesion Assessment (NCT07464340) | Zodiac Produtos Farmaceuticos S.A. | 2023-05-12 |
| A Food Effect Study of JAB-21822 in Healthy Subjects (NCT05875493) | Allist Pharmaceuticals, Inc. | 2023-05-12 |
| Effect of Bile Acids on Satiety, Cell Function and Body Weight in Patients With Obesity and Abnormal Satiety Phenotype (NCT05314374) | Mayo Clinic | 2023-05-12 |
| Safety, Blood Levels and Effects of AUT00201 in Patients With MEAK (NCT05873062) | Autifony Therapeutics Limited | 2023-05-12 |
| Thorough QT Study to Evaluate the Effect of Rodatristat Ethyl, Rodatristat and Its Major Metabolites on the Heart (NCT05933447) | Altavant Sciences GmbH | 2023-05-12 |
| XKH001 Injection in Healthy Subjects (NCT05991661) | Beijing Kanova Biopharmaceutical Co., LTD | 2023-05-12 |
| First-line Trastuzumab, Gemcitabine, Cisplatin and Nivolumab in Advanced HER2- Positive Biliary Tract Cancer: a Multicenter, Open-label, Single-arm Phase Ib/II Trial (HERBOT) (NCT05749900) | Yonsei University | 2023-05-12 |
| Study of VXCO-100, a SARS-CoV Candidate Vaccine in Healthy Adults in the United States (NCT05870839) | Vaccine Company, Inc. | 2023-05-11 |
| Botensilimab, Balstilimab and Regorafenib for the Treatment of Patients With Microsatellite Stable Metastatic Colorectal Cancer Who Have Progressed on Prior Chemotherapy (NCT05672316) | City of Hope Medical Center | 2023-05-11 |
| A Study of CDX-585 in Patients With Advanced Malignancies (NCT05788484) | Celldex Therapeutics | 2023-05-11 |
| LK101 Combined With PD-1 or PD-L1 Monoclonal Antibody in the Treatment of Lung Cancer (NCT05886439) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2023-05-11 |
| A Study to Evaluate ATP150/ATP152/ATP162, VSV-GP154 and Ezabenlimab in Patients With Pancreatic Ductal Adenocarcinoma (NCT05846516) | Boehringer Ingelheim | 2023-05-11 |
| XTX301 in Patients With Advanced Solid Tumors (NCT05684965) | Xilio Development, Inc. | 2023-05-11 |
| Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo (NCT05965167) | Entera Bio Ltd. | 2023-05-11 |
| Study of GS-4528 in Adults With Solid Tumors (NCT05840224) | Gilead Sciences | 2023-05-11 |
| Evaluation of RSV/Flu-01E Vaccine for the Prevention of RSV Infection in Volunteers Aged 18 to 59 Years and Over 60 Years (NCT05970744) | Tatyana Zubkova | 2023-05-10 |
| Evaluation of ТВ/Flu-05Е Vaccine for the Prevention of Tuberculosis Infection in BCG-vaccinated Volunteers Aged 18-50 Years (NCT05945498) | Tatyana Zubkova | 2023-05-10 |
| Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases (NCT06416709) | Cell Energy Life Sciences Group Co. LTD | 2023-05-10 |
| A Study to Assess Pharmacokinetics (PK) of Brensocatib Alone and With Multiple Doses of Rifampin or Esomeprozole in Healthy Participants (NCT05826574) | Insmed Incorporated | 2023-05-10 |
| A Phase 1 Dose Escalation Study of VX-973 in Healthy Adults (NCT05866055) | Vertex Pharmaceuticals Incorporated | 2023-05-10 |
| A Phase 1 Study of BRG01 in Subjects With Relapsed/Metastatic Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NCT05864924) | BioSyngen Pte Ltd | 2023-05-10 |
| A Clinical Trial Evaluated the Safety and Tolerability, Pharmacokinetic and Pharmacodynamics Profile, and Immunogenicity of a Single Dose of JS010 Injection in Healthy Subjects (NCT06158737) | Shanghai Junshi Bioscience Co., Ltd. | 2023-05-10 |
| A Platform Study to Evaluate Investigational Therapies in Chronic Hepatitis B Infection (NCT05612581) | Vir Biotechnology, Inc. | 2023-05-10 |
| Single and Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of NM-101 (NCT05790382) | Neuramedy Co. Ltd. | 2023-05-10 |
| Study of ZB001 in Chinese Patients With Thyroid Eye Disease (NCT05776121) | Zenas BioPharma (USA), LLC | 2023-05-10 |
| Evaluation of NM26-2198 in Healthy Subjects and in Patients With Moderate-to-severe Atopic Dermatitis (AD) (NCT05859724) | Yellow Jersey Therapeutics AG | 2023-05-10 |
| Study to Evaluate the Safety and Efficacy of ESC-derived Dopamine Progenitor Cell Therapy in PD Patients (NCT05887466) | S.Biomedics Co., Ltd. | 2023-05-09 |
| A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors (NCT05789069) | HiFiBiO Therapeutics | 2023-05-09 |
| A Clinical Study of ONCT-808 in Subjects With Relapsed or Refractory B-Cell Malignancies (NCT05588440) | Oncternal Therapeutics, Inc | 2023-05-09 |
| A Single and Multiple Ascending Dose Study of CK-4021586 in Healthy Adult Participants (NCT05877053) | Cytokinetics | 2023-05-09 |
| Phase 1 Study of CT-996 in Overweight/Obese Participants and Patients With Type 2 Diabetes Mellitus (NCT05814107) | Carmot Australia First Pty Ltd | 2023-05-09 |
| Effect of Alpelisib in Healthy Volunteers (NCT05733455) | Columbia University | 2023-05-09 |
| Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer (NCT05501665) | Vanderbilt-Ingram Cancer Center | 2023-05-09 |
| (89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma (NCT05747625) | Eben Rosenthal | 2023-05-09 |
| A Study to Assess Two Forms of The Study Medicine (Ritlecitinib) in Healthy Adult Participants (NCT05852340) | Pfizer | 2023-05-09 |
| Disitamab Vedotin, Fruquintinib and Tislelizumab in Second-line Treatment for HER2-positive MGC (NCT05982834) | Fudan University | 2023-05-09 |
| Safety, Tolerability of JMKX003002 in Phase 1 Study in Healthy Subjects (NCT05907382) | Jemincare | 2023-05-09 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK012 (NCT06565689) | Excyte Biopharma Ltd | 2023-05-09 |
| Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma (NCT05826535) | Lyell Immunopharma, Inc. | 2023-05-09 |
| A Study of Atropine Sulfate in Healthy Chinese Volunteers (NCT05855018) | Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited | 2023-05-09 |
| Oncorine (H101) Combined With Tislelizumab and Chemotherapy in Previously Untreated Advanced Non-small Cell Lung Cancer (NCT06136910) | Fujian Cancer Hospital | 2023-05-09 |
| Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies (NCT05039632) | M.D. Anderson Cancer Center | 2023-05-08 |
| A Phase Ib/II Clinical Study on AK112 Combined or Not Combined With AK119 in pMMR/MSS Colorectal Cancer (NCT05846867) | Akeso | 2023-05-08 |
| A Study of the Effects of Itraconazole or Carbamazepine on LY3537982 in Healthy Participants (NCT05860933) | Eli Lilly and Company | 2023-05-08 |
| A Study Evaluating the Safety and Efficacy of the GMCN-508A Drug Product in Transfusion-dependent α-Thalassemia Participants (NCT05757245) | First Affiliated Hospital of Guangxi Medical University | 2023-05-08 |
| A Study in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function (NCT05895812) | Shanghai Vinnerna Biosciences Co., Ltd. | 2023-05-08 |
| A Study of TAVO412 in Patients with Cancer (NCT05548634) | Tavotek Biotherapeutics | 2023-05-08 |
| Clinical Therapeutic Potential of Novel Microbiome LP-51 on Xerosis Individual Based on Xerosis-microbiome Index (NCT06706050) | Ho-Yeon Song | 2023-05-08 |
| Long-Term Follow-up of Gene Therapy for APOE4 Homozygote Alzheimer's Disease (NCT05400330) | Lexeo Therapeutics | 2023-05-08 |
| A FIRST IN HUMAN TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF SARS-CoV-2 UQSC2 VACCINE IN HEALTHY ADULTS. (NCT05775887) | The University of Queensland | 2023-05-08 |
| A Study of Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (CT103A) in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma (NCT05698303) | Nanjing IASO Biotechnology Co., Ltd. | 2023-05-08 |
| Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases (NCT05552469) | Novartis Pharmaceuticals | 2023-05-08 |
| Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1b) (NCT05085990) | Protara Therapeutics | 2023-05-08 |
| Nasal Irrigation With Combination of 0.9% NaCl and Binahong Extract (Anredera Cordifolia) 2,5% In Allergic Rhinitis (NCT05960526) | Gadjah Mada University | 2023-05-06 |
| IDH1 Inhibitor AB-218 in Patients With Advanced IDH1 Mutant Cholangiocarcinoma and Other Solid Tumor (NCT05814536) | AnHeart Therapeutics Inc. | 2023-05-06 |
| Selinexor、Venetoclax and Azactidine in the Treatment of ND AML Patients Who Are Not Eligible for Intense Chemotherapy (NCT06449482) | Institute of Hematology & Blood Diseases Hospital, China | 2023-05-05 |
| A Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]BMS-986419 in Healthy Male Participants (NCT05847439) | Bristol-Myers Squibb | 2023-05-05 |
| Multispectral Bimodal Fluorescence Guided Surgery of High-grade Glioma With Cetuximab-800CW and 5-ALA (5-aminolevulinic Acid) (NCT05929456) | University Medical Center Groningen | 2023-05-05 |
| Pharmacokinetics of IBI362 in Subjects With and Without Renal Impairment (NCT05793450) | Innovent Biologics (Suzhou) Co. Ltd. | 2023-05-05 |
| Dose-finding Study for the Combination of DMT and Harmine in Healthy Subjects (NCT05829603) | Reconnect Labs | 2023-05-05 |
| Clinical Study of Curcumin in Preventing Postoperative Adhesion of Bilateral Vocal Cords (NCT05688488) | Eye & ENT Hospital of Fudan University | 2023-05-05 |
| A Clinical Study Evaluating the Safety and Efficacy of SKG0106 in Patients With Neovascular Age-related Macular Degeneration (nAMD) (NCT06213038) | Youxin Chen | 2023-05-05 |
| OH2 Oncolytic Viral Therapy Via Transcatheter Intraarterial Infusion in Patients with Advanced Liver Cancer (NCT05698459) | Binhui Biopharmaceutical Co., Ltd. | 2023-05-05 |
| A Study Explore WJB001 Capsules in Patients With Advanced Solid Tumors (NCT05773820) | Wigen Biomedicine Technology (Shanghai) Co., Ltd. | 2023-05-05 |
| Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System Tumors (NCT05768880) | Seattle Children's Hospital | 2023-05-05 |
| Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML) (NCT05580601) | Children's Hospital Medical Center, Cincinnati | 2023-05-05 |
| Yttrium-90 Carbon Microspheres in Patients With Unresectable Hepatocellular Carcinoma (NCT05957640) | Zhongda Hospital | 2023-05-05 |
| A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer (NCT05859074) | Memorial Sloan Kettering Cancer Center | 2023-05-04 |
| A Study to Compare Two Bioanalytical Assays for Tebipenem (NCT05856747) | Spero Therapeutics | 2023-05-04 |
| Intra-Arterial Chemotherapy for Newly Diagnosed, Residual, or Recurrent Atypical Choroid Plexus Papilloma and Choroid Plexus Carcinoma Prior to Second-Look Surgery (NCT04994977) | Weill Medical College of Cornell University | 2023-05-04 |
| Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Severe Peripheral Nerve Injury (PNI) (NCT05541250) | W. Dalton Dietrich | 2023-05-04 |
| RC1012 Injection (Allo-DNT Cells) for the Prevention of Relapse in AML Patients After Allo-HSCT (NCT05858814) | Guangdong Ruishun Biotech Co., Ltd | 2023-05-04 |
| Food Effects of GST-HG171 Tablets Combined With Ritonavir in Healthy Chinese Participants (NCT06084507) | Fujian Akeylink Biotechnology Co., Ltd. | 2023-05-04 |
| Effect of Oral 6-bromotryptophan on Safety, Pharmacokinetics and Efficacy in Metabolic Syndrome Individuals (NCT05971524) | Nordin Hanssen | 2023-05-04 |
| FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Microsatellite Stable (MSS) Metastatic Colorectal Cancer (NCT05627635) | City of Hope Medical Center | 2023-05-03 |
| Allogeneic γ9δ2 T Cells Treatment of Recurrent Hematologic Tumors (NCT05755854) | Anhui Provincial Hospital | 2023-05-03 |
| Phase Ib Trial of the KRASG12C Inhibitor Adagrasib (MRTX849) in KRAS G12C Mutant Metastatic Pancreatic Cancer Patients (NCT05634525) | M.D. Anderson Cancer Center | 2023-05-03 |
| Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer (NCT04799431) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2023-05-03 |
| Nivolumab With Ipilimumab Combined With TGFβ-15 Peptide Vaccine and Radiotherapy for Pancreatic Cancer (NCT05721846) | Inna Chen, MD | 2023-05-03 |
| A Drug-Drug Interaction Study of ENV-101 (Taladegib) on Nintedanib Pharmacokinetics in Healthy Subjects (NCT05817240) | Endeavor Biomedicines, Inc. | 2023-05-03 |
| POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC (NCT05782361) | Institute of Cancer Research, United Kingdom | 2023-05-03 |
| A Study to Evaluate the Effect of Food on the Pharmacokinetics of VX-548 (NCT05851157) | Vertex Pharmaceuticals Incorporated | 2023-05-03 |
| Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis (NCT05094908) | Universidad de Antioquia | 2023-05-03 |
| A Study in Healthy Men to Test How BI 764198 is Processed in the Body (NCT05863130) | Boehringer Ingelheim | 2023-05-03 |
| A Study to Evaluate the Safety and Bridging PK Profile of FB825 for Single Subcutaneous Administration in Healthy Adults (NCT05952986) | Oneness Biotech Co., Ltd. | 2023-05-03 |
| A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer (NCT05800665) | Genentech, Inc. | 2023-05-02 |
| Ingestion Effect of Formula Milk With Triple Bifidobacteria Strains on Fecal Quality and Metabolites in Healthy Children (NCT06044376) | Gadjah Mada University | 2023-05-02 |
| Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas (NCT05139056) | City of Hope Medical Center | 2023-05-02 |
| Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B (SAFRAN) (NCT06120582) | Biocad | 2023-05-02 |
| A Study to Compare How Much of the Study Treatment Finerenone Gets Into the Blood When the Same Amount is Taken in One and in Two Tablets of Different Strengths in Healthy Male Participants (NCT07116512) | Bayer | 2023-05-02 |
| Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT) (NCT05878184) | Sana Biotechnology | 2023-05-02 |
| Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (13.3mg/24h) (NCT05853341) | Luye Pharma Group Ltd. | 2023-05-02 |
| Metformin Treatment in Infants After Perinatal Brain Injury (NCT05590676) | The Hospital for Sick Children | 2023-05-02 |